Nipradilol, a new β-adrenergic blocker, reduces left ventricular remodeling following myocardial infarction in spontaneously hypertensive rats

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Heart and Vessels

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01747498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardioprotective and antiarrhythmic effects ofβ-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia

  2005cited by this paper
• An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat.

  1995cited by this paper
• Effect of prolonged beta-adrenergic blockade induced by atenolol on left ventricular remodeling after acute myocardial infarction in the rat.

  1995cited by this paper
• Bioenergetic consequences of left ventricular remodeling.

  1995cited by this paper
• Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.

  1994cited by this paper
• Post-myocardial infarction ventricular remodeling: Animal and human studies

  1994cited by this paper
• Effect of prolonged nitrate therapy on left ventricular remodeling after canine acute myocardial infarction.

  1994cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

  1993cited by this paper
• Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

  1993cited by this paper
• Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog.

  1993cited by this paper
• Possibilities of the tolerance development to nipradilol and of the measurement of vascular glutathione content in isolated rat aorta.

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Progressive ventricular remodeling in rat with myocardial infarction.

  1991cited by this paper
• Chronic Propranolol Treatment Promotes Left Ventricular Dilation Without Altering Systolic Function After Large Myocardial Infarction in Rats

  1990cited by this paper
• Beneficial effect of nipradilol (K-351) on acute myocardial ischemia. Study of the relationship between regional myocardial blood flow and energy metabolism.

  1990cited by this paper
• Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.

  1990cited by this paper
• Prognosis and management after a first myocardial infarction.

  1990cited by this paper
• Angiotensin and the remodelling of the myocardium.

  1989cited by this paper
• Importance of Venodilatation in Prevention of Left Ventricular Dilatation After Chronic Large Myocardial Infarction in Rats: A Comparison of Captopril and Hydralazine

  1989cited by this paper
• Increased afterload aggravates infarct expansion after acute myocardial infarction.

  1988cited by this paper
• Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location.

  1988cited by this paper
• Long-term propranolol administration alters myocyte and ventricular geometry in rat hearts with and without infarction.

  1988cited by this paper
• Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis.

  1988cited by this paper
• Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

  1987cited by this paper
• Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.

  1986cited by this paper
• Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties.

  1986influential reference
• Venodilating action of nipradilol (K-351) in the pithed rat pretreated with dihydroergotamine.

  1985cited by this paper
• Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat

  1985influential reference
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• Effects of K-351 on hemodynamics and renin release in anesthetized dogs.

  1984cited by this paper
• The effects of 3,4‐dihydro‐8‐(2‐hydroxy‐3‐isopropylaminopropoxy)‐3‐nitroxy‐2H‐1‐benzopyr an (K‐351) and its denitrated derivative on smooth muscle cells of the dog coronary artery

  1983cited by this paper
• Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.

  1983cited by this paper
• Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs.

  1981cited by this paper
• Left Ventricular Diastolic Pressure‐Volume Relations in Rats with Healed Myocardial Infarction: Effects on Systolic Function

  1981cited by this paper
• Similarities of Genetic (Spontaneous) Hypertension: Man and Rat

  1981cited by this paper
• Protective effects of β-adrenergic blockade in isolated ischemic hearts☆

  1980cited by this paper
• Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations.

  1979cited by this paper
• Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.

  1978cited by this paper

• Neural mechanism of angiotensin-converting enzyme inhibitors in improving heart rate variability and sleep disturbance after myocardial infarction.

  2018cites this paper
• Pharmacodynamic hybrids coupling established cardiovascular mechanisms of action with additional nitric oxide releasing properties.

  2009cites this paper
• Direct measurement of nipradilol-derived nitric oxide in the vascular wall of canine femoral arteries

  2005cites this paper
• Cardioprotection afforded by ischemic preconditioning interferes with chronic beta‐blocker treatment

  2004cites this paper
• Nipradilol inhibits atmospheric pressure-induced cell proliferation in human aortic smooth muscle cells.

  2004cites this paper